# Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer

> **NCT06441994** · PHASE1 · RECRUITING · sponsor: **Osaka University** · enrollment: 15 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** PSW-1025

## Key facts

- **NCT ID:** NCT06441994
- **Lead sponsor:** Osaka University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-24
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06441994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06441994, "Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06441994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*